Raleigh, N.C. – December 5, 2016 – Valencell, the leading innovator in performance biometric data sensor technology, announced today that the Director of its Biometrics Laboratory, Chris Eschbach, Ph.D., EP-C, CSCS, will participate in a panel discussion on mHealth integration at the Exercise is Medicine® (EIM) Conference and Think Tank, The Wild Wild West of Quantified Healthcare: A Conference and Think Tank on mHealth Integration, taking place in Atlanta, Georgia, December 5-6, 2016.
EIM is a global health initiative managed by the American College of Sports Medicine (ACSM) that is focused on encouraging primary care physicians and other health care providers to include physical activity when designing treatment plans for patients.
The EIM conference and think tank will serve as a forum to help establish a framework for integrating objective physical activity data into routine health care delivery, to help refine the development of wellness programs and clinical interventions for the prevention and management of common and costly diseases related to inactivity. The conference will bring together representatives from a variety of industries, including wearables manufacturers, app developers, large health plans and integrated health systems, health information regulatory agencies, and electronic medical record and data aggregation software companies to have a collaborative dialogue focused on sharing best practices and developing solutions to integration and implementation challenges.
Panelists speaking at the event include representatives from the American College of Sports Medicine, Emory University School of Medicine, U.S. Centers for Disease Control, U.S. Department of Health and Human Services among others. The conference will take place on Monday, December 5th from 8:00 – 6:00 p.m. at the Emory Conference Center, Atlanta, Georgia.
Valencell’s PerformTek® sensor systems provide accurate, robust and flexible technology, powering more biometric hearables and wearables on the market than any other company. The technology gives hearable devices the ability to continuously and accurately measure blood flow signals, even during extreme physical activity or when the optical signals are weak. These signals can be translated into biometric data, including continuous heart rate, VO2 and VO2 max, resting heart rate, heart rate response, heart rate recovery, continuous energy expenditure (calorie burn), cardiac efficiency and heart rate variability assessments.
The accuracy of Valencell’s PerformTek technology has been independently validated by numerous research institutions, including Duke University, NC State University, and the American College of Sports Medicine.
Valencell provides its biometric sensor technology through it Benchmark™ sensor system, a turnkey biometric sensor system with the complete PerformTek technology package ready for immediate integration into wearable and hearable devices. Valencell also offers product licensing and patent licensing, to enable customers to create custom-designed biometric hearable and wearable devices.
Valencell has a highly cited patent portfolio in optical biometric sensor technology in the wearables and hearables industry, which includes 38 patents granted and more than 90 additional patents pending.
Valencell’s PerformTek technology is the choice of popular consumer electronics brands, including Samsung, Sony, LG, Intel/SMS Audio, Jabra, Scosche, Atlas Wearables, Caeden, Kuaiwear, Bioconnected, and iriver among numerous others. To learn more about licensing PerformTek, visit valencell.com/access.
For more information, or to set up a meeting with Chris Eschbach at the EIM conference and think tank, please contact firstname.lastname@example.org.
Valencell develops performance biometric sensor technology and licenses this patent-protected technology to consumer electronics manufacturers, wearable and hearable device makers, sports and fitness brands, medical device makers, and gaming companies for integration into their products. Valencell’s PerformTek® biometric sensor technology employs active signal characterization, the process of segmenting raw signal data from biometric sensors into biological, motion, and environmental signals and noise. Valencell has invested years into the research and development of its PerformTek sensor technology, protected by dozens of granted patents and independently validated by the Duke Center for Living, North Carolina State University, the Human Performance Laboratory and a fellow of the American College of Sports Medicine.